Treatment strategy and therapy based on immune response in patients with gastric cancers

doi:10.4240/wjgs.v16.i8.2393

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3210)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

118

WORD

HTML

1023

Sum=1146

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

359

Download

691

Sum=1050

Publishing Process of This Article

Item

Count

Browse

267

Download

610

Sum=877

Aug 27, 2024 (publication date) through Mar 13, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Surg. Aug 27, 2024; 16(8): 2393-2395
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2393

Treatment strategy and therapy based on immune response in patients with gastric cancers

Damian Jacenik, Jakub Fichna

Damian Jacenik, Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, Poland

Jakub Fichna, Department of Biochemistry, Medical University of Lodz, Lodz 92-215, Poland

Author contributions: Jacenik D and Fichna J wrote, reviewed and edited the manuscript; Jacenik D wrote the original draft and conceptualised the manuscript.

Conflict-of-interest statement: The authors declare having no conflicts of interest.

Corresponding author: Damian Jacenik, PhD, Assistant Professor, Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., Lodz 90-236, Poland. damian.jacenik@biol.uni.lodz.pl

Received: April 3, 2024
Revised: May 7, 2024
Accepted: June 4, 2024
Published online: August 27, 2024
Processing time: 135 Days and 8.9 Hours

Abstract

In this editorial, we highlight the significance of a retrospective study “Analysis of the impact of immunotherapy efficacy and safety in patients with gastric cancer and liver metastasis” performed by Liu et al. The authors utilized data collected from gastric cancer (GC) patients and assessed immunotherapy effectiveness and survival status. They found significant differences in treatment response. Because immunotherapy seems to be a beneficial strategy for advanced GC patients, stratification of the data based on metastasis status may further improve treatment strategies.

Keywords: Gastric cancer; Metastasis; Immunotherapy; Treatment strategy

Core Tip: Gastric cancer (GC) is a highly heterogenous disease that affects patients’ outcomes. Immunotherapy in GC patients seems to provide several clinical benefits, and retrospective studies are needed to evaluate immunotherapy efficiency and safety. The aim of this editorial is to provide a short and informative introduction elaborating the efficiency and safety of immunotherapy in patients with advanced GCs manifested by absence or presence of liver metastasis.